Crossing the Blood–Brain Barrier: Innovations in Receptor- and Transporter-Mediated Transcytosis Strategies
The blood–brain barrier (BBB) is a highly selective and natural protective membrane that restricts the entry of therapeutic agents into the central nervous system (CNS). This restrictive nature poses a major challenge for pharmacological treatment of a wide range of CNS disorders, including neurodeg...
Saved in:
| Main Authors: | Ling Ding, Pratiksha Kshirsagar, Prachi Agrawal, Daryl J. Murry |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/17/6/706 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of transcytosis in the blood-retina barrier: from pathophysiological functions to drug delivery
by: Chun-Lin Zhang, et al.
Published: (2025-04-01) -
Caveolae-Mediated Transcytosis and Its Role in Neurological Disorders
by: Kunjian Yang, et al.
Published: (2025-03-01) -
Modifying antibody-FcRn interactions to increase the transport of antibodies through the blood-brain barrier
by: Jason Tien, et al.
Published: (2023-12-01) -
The effects of dose, valency, and affinity on TfR-mediated brain delivery in vivo
by: Gillian Bonvicini, et al.
Published: (2025-04-01) -
Advances in brain-targeted delivery strategies and natural product-mediated enhancement of blood–brain barrier permeability
by: Suyi Liu, et al.
Published: (2025-05-01)